| Autor: |
Tillmann FP; Medical Centre Cologne-Merheim, Department of Medicine I-Nephrology, Transplantation & Medical Intensive Care, University Witten/Herdecke, D-51109 Cologne, Germany.; Centre for Nephrology and Hypertensiology Ibbenbüren, Gravenhorsterstr. 1, D-49477 Ibbenbüren, Germany., Figiel L; Centre for Nephrology and Hypertensiology Emsdetten, D-48282 Emsdetten, Germany., Ricken J; Centre for Nephrology and Hypertensiology Rheine, D-48431 Rheine, Germany., Still H; Centre for Nephrology and Hypertensiology Ibbenbüren, Gravenhorsterstr. 1, D-49477 Ibbenbüren, Germany., Korte C; Centre for Nephrology and Hypertensiology Emsdetten, D-48282 Emsdetten, Germany., Plassmann G; Centre for Nephrology and Hypertensiology Rheine, D-48431 Rheine, Germany., von Landenberg P; LADR GmbH MVZ Nord-West, D-48465 Schüttorf, Germany. |
| Abstrakt: |
The aim of this investigation was to determine the effect of SARS-Cov-2 vaccination in hemodialysis patients, search for risk factors for non- or low-response, and to measure the effect of a third booster vaccination in non- or low-responders. Methods SARS-CoV-2 IgG antibodies and the virus-neutralizing capacity were measured 4-5 weeks after a full standard vaccination in 95 chronic hemodialysis patients and 60 controls. IgG titers > 30 AU/mL served to classify participants as responders. Multivariable binary logistic regression analysis was used to search for risk factors of reduced vaccination success. Patients with vaccination failure were offered a third booster dosage. Results 82.1% of the patient cohort as compared to 98.3% of the healthy control group were able to mount SARS-CoV-2 titers above 30 AU/mL after two standard vaccine doses. Mean IgG antibody titers were lower in hemodialysis patients than controls (78 ± 35 vs. 90 ± 20 AU/mL, p = 0.002). Multivariable binary logistic regression analysis showed age and immunosuppressive medication as major risk factors for vaccination failure with a decreased probability of successful vaccination of -6.1% (95% CI -1.2 to -10.9) per increase in age of one year and -87.4% (95% CI -98.0 to -21.5) in patients on immunosuppressive therapy (crude odds ratio for vaccination failure for immunosuppressive therapy 6.4). Ten out of 17 patients with non-response to vaccination were offered a third dose. Booster vaccination after the second dose induced an increase in effective antibody titers of >30 AU/mL in seven out of ten patients 4-5 weeks later (70%). Conclusion Standard SARS-CoV-2 vaccination schemes are highly effective in mounting protective neutralizing IgG antibodies in chronic hemodialysis patients. Nevertheless, response to vaccination is diminished as compared to a healthy control group. Major risk factors for vaccination failure are older age and immunosuppressive therapy. In non- or low-responders to standard vaccination a third booster vaccination was able to induce effective antibody titers in about 70% of patients, indicating that a third booster vaccination might be preferable to decreasing immunosuppressive therapy. |
